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The Epidemiology of Diabetes in Korea:  
From the Economics to Genetics
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Department of Preventive Medicine, Ajou University School of Medicine, Suwon, Korea
To determine the factors responsible for the dramatic increase in the prevalence of diabetes in Korea. A computerized literature 
survey was conducted to evaluate the risk factors for Type 2 diabetes mellitus (T2DM) in Korea, including genome-wide associa-
tion studies. National Statistics gross national income data was integrated with the reported prevalence of diabetes to evaluate the 
relationship between diabetes and the economic growth. The strength of the association was evaluated using measures of effect 
size, such as odds ratio and relative risks. The putative risk factors identified in Korean studies are very similar to the risk factors 
identified from the other countries, including genetic background. Genome-wide association studies reported relative risks of 1.5 
or less, indicating that no single gene is associated with the risk of T2DM. The scientific evidence suggests that the dramatic in-
crease in the incidence and prevalence of T2DM in Korea is related to the economic development of Korea, which has a direct in-
fluence on health policy, as well as an individual’s health behaviors. We expect to observe the current diabetes incidence rates un-
til the key risk factors are present for long enough in our society, at which point we would expect to start observing a more grad-
ual increase in both the incidence and prevalence of T2DM in Korea.
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INTRODUCTION
Type 2 diabetes mellitus (T2DM) is a major health problem af-
fecting more than 170 million people worldwide, with a major 
increase expected in Asia in the next 20 years, as indicated by 
the predicted doubling of the diabetic populations in India and 
China [1]. In the USA, more than 13% of adults over the age of 
20 years have been diagnosed with T2DM [2]. T2DM is also a 
major chronic disease and public health problem in Korea. The 
prevalence of diabetes mellitus in Korea increased from less 
than 1% in 1960 to 6-9% by the end of the 1990s [3,4]. The rap-
id rise in the prevalence of diabetes and cardiovascular disease 
in Korea may be related to an increasingly Westernized diet, de-
creased physical activity, an increasing obese population, and 
genetic background [5]. The putative risk factors for T2DM in 
the Korean population include (but are not limited to) increas-
ing age, urban living, female gender, obesity, smoking, family 
history of diabetes, impaired liver function, metabolic syndrome, 
elevated blood pressure, and increased triglycerides. For a bet-
ter understanding of T2DM in Korea, the magnitude of the prev-
alence, incidence, and risk factors still needs to be evaluated.
  The most recent report from a large size community cohort 
prospective study revealed the age, gender, and resident specific 
annual incidence of T2DM was 1.33%, 1.55%, 1.68%, and 2.35% 
in 40-year-old rural female, urban female, rural male, and urban 
male, respectively. In 50-year-old the rate increased to 1.48% 
in rural female, 1.65% in rural male, 2.3% in urban female, and 
3.18% in urban male. In 60-year-old, 1.85% in rural male, 2.05% 
in rural female, 4.1% in urban female, and 4.55% in urban male. 
In 70-year-old, the rate increased to 3.08% in rural female, 3.93% 
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in rural male, 5% in urban female, and 5% in urban male. The 
incidence rates stratified by age and gender in rural subjects 
showed ‘J’ shaped pattern, but linear pattern was observed in 
urban subjects.
  The prevalence of T2DM was 5.2%, 5.4%, 7.5%, and 10% in 
40-year-old urban women, rural women, rural men, and urban 
men, respectively. In 50-year-old, the prevalence increased to 
10.9% in urban women, 13.5% in rural women, 14.9% in rural 
men, and 16.5% in urban men. In 60-year-old, the prevalence 
was 16.5% in rural men, 17.5% in rural women, 17.5% in urban 
women, and 24.8% in urban men. A relatively higher prevalence 
was observed in the urban and male populations [6].
ECONOMY AND DIABETES
Korea has experienced a dramatic increase in the prevalence 
of diabetes since the early 1990s; however, the rapid increase 
in the prevalence of chronic disease could be the result of vari-
ous artifacts, rather than being the consequence of risk factors. 
The artifacts responsible for dramatic changes of the prevalence 
and incidence of chronic disease in Korea include:
1) Changes in diagnostic methods and criteria,
2) Changes in national health policy and the health insurance 
system,
3) Promotion of disease awareness, and
4) A sudden change or increased exposure to key risk factors.
However, it is almost impossible for exposure of a large popu-
lation to a key risk factor to result in a such dramatic increas-
ing pattern of chronic diseases. For example, chronic diseases, 
such as diabetes, are the consequence of exposure to multiple 
risk factors over a long period of time. In other words, expo-
sure to multiple risk factors from the environment, lifestyle, 
and habitual factors results in the progression of disease at dif-
ferent rates among individuals and in a gradual pattern. There-
fore, the onset of diabetes occurs based on the individual’s sus-
ceptibility, immunity, and exposure amount, as well as on the 
duration of the risk factors and incubation period. Thus, the 
dramatic change in the patterns of incidence and prevalence 
of diabetes are related to economic changes of individual na-
tions, as well as the individual’s health behavior.
  As shown in Fig. 1, Korea has experienced both steady eco-
nomic growth and an increasing prevalence of diabetes. In the 
early 1970s, epidemiologic studies from Korea reported a T2DM 
prevalence of less than 2%; however, a log linear increase in 
prevalence was observed, starting in 1987. This is an unusual 
pattern if the prevalence is the result of the risk exposure, as 
one would expect a gradual linear increase if the prevalence is 
related to risk exposure. The Korean government implement-
ed a universal health insurance system in 1987, and the preva-
lence of diabetes clearly reflects a “seeking of disease” concept. 
This hypothesis is further supported by the fact that the Kore-
an gross national income is curtailing the prevalence pattern 
of diabetes (Fig. 1). Diabetes awareness campaigns, individu-
als’ health care attitudes and interest, screening programs, and 
national health care coverage are relate to the higher prevalence 
of diabetes and contribute to the logarithmic prevalence pattern. 
The most recent study from the National Health Insurance Cor-
poration and the Bureau of National Statistics indicated a total 
of 2 million people with diabetes in Korea [7]. However, this 
report did not include asymptomatic cases, which are present 
in about the same amount as known cases. If we include asymp-
tomatic cases, as well as impaired glucose tolerance cases, we 
would estimate somewhere around 4-5 million people with 
T2DM or at high risk for T2DM in Korea [8].
  We suggested that the rapid rise in both incidence and prev-
alence of diabetes in Korea is largely due to national health 
policy; however, to some degree, the rise is due to exposure to 
multiple risk factors. Thus, let us evaluate the risk factors of the 
T2DM in Korea and the magnitude of these risk factors.
RISK FACTORS
The putative risk factors for T2DM in the Korean population 
include (but are not limited to) old age, urban living, female 
gender, obesity, smoking, family history of diabetes, impaired 
liver function, metabolic syndrome, elevated blood pressure, 
and increased triglycerides. Although some risk factors have 
yet to be identified, the aforementioned variables are the key 
risk factors for diabetes mellitus in Koreans. Most of these risk 
factors have also been identified as key risk factors in other lo-
cations, including Europe, South and North America, and Af-
rica. Moreover, seventy percent of identified risk factors are 
modifiable. For example, smoking is a habitual behavior and is 
modifiable. Several prospective studies have demonstrated the 
risk association between cigarette smoking and diabetes in both 
Caucasian and Asian populations [9-14]. In the 21,068-partic-
ipant U.S. Physicians’ Health Study, both former and current 
smokers had an increased risk of self-reported diabetes in a 12
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dose-response relationship. Similarly, in the Nurses’ Health 
Study, a dose-dependent relationship between smoking and 
diabetes incidence among 114,247 female nurses had been re-
ported [15]. Although these dose-relationships were not always 
consistent, this may be due to differences in study design, par-
ticipant characteristics, and measurement methods [10,16,17]. 
In a study from Korea, smokers (ex- and current) had a higher 
incidence of diabetes mellitus than never-smokers (6.3% vs. 
5.1%, P < 0.05). The incidence of diabetes was 5.1%, 8.3%, 5.1%, 
and 6.8% in never-smokers, ex-smokers, current smokers, and 
heavy smokers, respectively (P < 0.05). In this study, compared 
to never smokers, the ex- and heavy smokers had a 2-fold in-
creased risk of diabetes, while current smokers had a 1.5-fold 
increased risk. Furthermore, the population attributable risk 
of smoking for diabetes was 14% (95% confidence interval [CI], 
4.4% to 23.6%) [18]. In other words, if no smokers were pres-
ent in Korea, then 14% of the cases of diabetes could be pre-
vented. In, addition, urban living, obesity, impaired liver func-
tion, metabolic syndrome, elevated blood pressure, and in-
creased triglycerides are all modifiable risk factors and all in-
dependently contribute to the risk of diabetes. The relationship 
between liver function and T2DM has been investigated in 
numerous clinical and epidemiologic studies. In a study in 
Korea, ALT levels had a dose-dependent effect on the preva-
lence of T2DM at baseline examination from 3.2%, 4.1%. 6.3%, 
and 12.5% (c
2 = 256.8; P < 0.001) in lowest to highest quartile 
groups, respectively. However, at the follow-up evaluation, the 
incidence of T2DM was 2.5%, 2.3%, 4.0%, and 7.1% for the re-
spective quartile groups. The relative risks were 0.9 (95% CI, 
0.55 to 1.53; P = ns), 1.67 (1.06 to 2.6; P < 0.05), and 3 (1.97 to 
4.7; P < 0.001), when compared to the lowest quartile group. 
Furthermore, a multiple logistic regression analysis revealed 
that age-adjusted relative risk was 1.34 (95% CI, 0.98 to 1.85; P 
= 0.07) in the 2nd quartile, 1.91 (1.41 to 2.59; P < 0.001) in the 
3rd quartile, and 2.95 (2.17 to 4.0; P < 0.001) in the 4th quartile 
group, when compared to the lowest quartile group [19].
  The rise of diabetes incidence and prevalence in Korea is a 
result of both health policy change and exposure to putative risk 
factors. In the past 10 years, genetic susceptibility has emerged 
as a new key risk factor for T2DM. We will now evaluate the 
strength of genetics as a risk factor of T2DM.
GENETICS AND DIABETES
The genome-wide association (GWA) approach is an emerging 
methodology that enables us to identify genetic variants with 
Fig. 1.  The prevalence of diabetes and gross national income (GNI).
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specific loci predisposing individuals to complex traits and dis-
eases [20]. Several genes identified through linkage scans or the 
candidate gene approach have been confirmed to be associat-
ed with T2DM (e.g., PPARG, KCNJ11, HNF4A, and CAPN10). 
Furthermore, under the common variant-common disease hy-
pothesis, several GWA studies on T2DM have been conducted 
in large-scale case-control samples. Seven novel genes (TCF7L2, 
SLC30A8, HHEX, CDKAL1, CDKN2A and CDKN2B, IGF2BP2, 
and FTO) have been reproducibly demonstrated to have a mod-
est association with T2DM (odds ratio [OR], 1.12 to 1.37) in 
multiple populations of European ancestry [21-25]. While 
many of the genes are implicated in the insulin production/ 
secretion pathway (TCF7L2, SLC30A8, HHEX, CDKAL1,   
CDKN2A/B and IGF2BP2), FTO is associated with T2DM 
through its regulation of adiposity [25,26]. Moreover, a region 
near CDKN2A/B is associated with risk of both T2DM and 
cardiovascular diseases [27,28]. Despite consistent associations 
among Europeans, the contributions of these genetic variants 
in other ethnic groups are unclear. Given the differences in en-
vironmental factors (e.g., lifestyle), risk factor profiles (body 
composition and insulin secretion/resistance patterns), and 
genetic background (linkage disequilibrium pattern and risk 
allele frequencies) between Europeans and Asians, it is impor-
tant to understand the role of these genes in Asians.
  Recent GWA studies have been performed in a Chinese pop-
ulation in Hong Kong (involving 6,795 T2DM cases and non-
diabetic controls) and two Korean populations. The risk alleles 
were consistent among the three Asian populations and were 
consistent with those reported in Europeans [21-25]. TCF7L2 
(rs7903146) showed the strongest effect (OR, 1.34), followed 
by CDKN2A/B (rs10811661), CDKAL1 (rs7754840 and rs7756 
992), HHEX (rs1111875, rs5015480 and rs7923837), SLC30A8 
(rs13266634), IFG2BP2 (rs4402960), and FTO (rs8050136). 
Haplotype analyses did not reveal a more significant associa-
tion than single-marker analyses. Interestingly, multiple single 
nucleotide polymorphisms at CDKAL1 and HHEX were signif-
icantly associated with T2DM risk. However, only rs10811661 
near CDKN2A/B was highly significant for association with 
T2DM.
  Since the reported T2DM genes may be implicated in dif-
ferent metabolic pathways, subset analyses were performed by 
dividing the T2DM patients into non-obese (body mass index 
[BMI] <25 kg/m
2) and obese subgroups using the Asian guide-
line for the definition of obesity [28]. The study found that the 
associations for T2DM were significantly higher in the non-
obese subgroup, as compared to the obese subgroup in the 
combined samples for CDKAL1 (rs7754840) and CDKN2A/B 
(rs10811661) (OR, 1.29 vs. 1.15 and 1.39 vs. 1.20 in non-obese 
and obese subgroups, respectively, heterogeneity P < 0.05). The 
former association in non-obese diabetes was also observed in 
an Icelandic population [24]. On the other hand, FTO showed 
a stronger association in the obese subgroup (OR, 1.06 vs. 1.27 
in non-obese vs. obese subgroups, heterogeneity P < 0.05). The 
result for FTO is consistent with the finding that the T2DM as-
sociation was lost after adjustment for BMI (OR, 1.18; P = 0.003 
vs. OR, 1.09; P = 0.126 before and after adjustment for BMI, 
respectively). Moreover, the risk allele of FTO was highly asso-
ciated with increased BMI in the combined samples (P = 1.7 × 
10
-6). Taken together, FTO alters the risk for T2DM, primarily 
through effects on adiposity, which is consistent with reported 
findings in Europeans [25,26,29]. In addition to BMI, the risk 
alleles for SLC30A8 (rs13266634) and HHEX (rs1111875) were 
significantly associated with diagnosis at an earlier age [30].
  These studies provide important insight into the impact of 
the new T2DM genes identified through genome-wide associ-
ation studies. However, the strength of the effect size is not as 
strong as some of the risk factors, such as family history of dia-
betes. Therefore, we are inclined to believe that the link between 
diabetes and genetic susceptibility is genuine, but, however, is 
not a key risk factor for T2DM.
SUMMARY
Numerous epidemiologic studies from Korea have revealed a 
high rate of diabetes. Although the effect sizes are different, the 
putative risk factors identified from Korean studies are very sim-
ilar to the risk factors identified from the other countries. Fur-
thermore, the genes identified through genome-wide associa-
tion studies conducted in both Asian and Caucasian popula-
tions revealed a lower effect size. These genetic studies report-
ed a relative risk of 1.5 or less, indicating that no single gene is 
associated with the risk of T2DM; however, a strong interaction 
between genetic factors and lifestyle, diet, and habitual factors 
was suggested. In addition, relative risk (RR) and OR are statis-
tics that only describe an association, not causation. RR and 
OR also refer to a population and not to an individual patient. 
Furthermore, studies of small groups are more likely to find an 
association that might actually be due to chance, while larger 
groups are less likely to show an association between a risk fac-
tor and an outcome. Finally, when the incidence of an outcome 14
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of interest in the study population is low (<10%), the OR is close 
to the RR; the more frequent the outcome becomes, the more 
the OR will overestimate the RR when OR is greater than 1 or 
underestimate the RR when OR is less than 1.
  In conclusion, the high incidence and prevalence of T2DM 
in Korea is related to economic development, which has a direct 
influence on health policy, as well as an individual’s health be-
haviors, and which is associated with a high rate of T2DM. En-
vironmental and genetic factors very likely contribute to some 
degree to the high rate of diabetes in Korea. Finally, although 
genetic factors are independently associated with an onset of 
T2DM, the strength of an association is less than that of the en-
vironmental risk factors that have been reported. Therefore, we 
expect to observe the current diabetes rates until the key risk 
factors incubate long enough in our society, at which point we 
would expect to start observing a more gradual increase in both 
the incidence and prevalence of T2DM in Korea.
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